Riskpilot← Back to searchSign inGet full accessTromp Medical ApS
APSActiveCVR 25444531Søren Frichs Vej 38DWholesale of pharmaceutical and medical goods · NACE 4646Est. 200016 employeeswww.trompmedical.dk
Revenue 2025
DKK 25,1M
+29% vs 2024
EBITDA margin
39.2%
+65% vs 2024
Equity ratio
45.1%
Financial strength
Net profit 2025
DKK 7,7M
+60% vs 2024
| Revenue | DKK 25,1M | +29% |
| EBITDA | DKK 9,8M | +65% |
| Net profit | DKK 7,7M | +60% |
| Total assets | DKK 60,7M | +36% |
| Equity | DKK 27,4M | +11% |
| Employees | 16 | — |
Legal name
Tromp Medical ApS
CVR number
25444531
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24. maj 2000
Share capital
DKK 125.000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et bestyrelsesmedlem i forening med en direktør
Company purpose
Selskabets formål er salg, vedligeholdelse, reparation, service og applikation af/på røntgenudstyr og andet medicinsk udstyr, tilbehør og dermed beslægtet virksomhed.
Address
Søren Frichs Vej 38D
Phone
+4570212870
Email
mail@trompmedical.dk
Website
www.trompmedical.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 22.243 | 23.456 | 18.396 | 19.385 | 25.071 |
| Staff expenses | -13.161 | -14.287 | -12.544 | -13.430 | -15.248 |
| EBITDA | 9.082 | 9.170 | 5.851 | 5.945 | 9.823 |
| Depreciation & amort. | -92 | -118 | -56 | -83 | -192 |
| EBIT | 8.990 | 9.052 | 5.796 | 5.862 | 9.631 |
| Net financials | 254 | 288 | 543 | 361 | 269 |
| Profit before tax | 9.244 | 9.339 | 6.339 | 6.223 | 9.900 |
| Tax | 2.059 | 2.082 | 1.416 | 1.400 | 2.198 |
| Net profit | 7.186 | 7.258 | 4.923 | 4.823 | 7.702 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 58.518 | 67.046 | 50.482 | 44.502 | 60.733 |
| Equity | 25.171 | 24.929 | 24.851 | 24.674 | 27.376 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 30.491 | 39.858 | 23.893 | 18.305 | 32.443 |
| Total debt | 30.491 | 39.858 | 23.893 | 18.305 | 32.443 |
EBITDA margin
39.2%
This company
15.8%
Market median
+148% vs market
20212025
Equity ratio
45.1%
This company
38.2%
Market median
+18% vs market
20212025
Return on equity
28.1%
This company
18.4%
Market median
+53% vs market
20212025
Net profit margin
30.7%
This company
8.1%
Market median
+279% vs market
20212025
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20212025
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BA Management | Management | 2001 |
| Former (2) | ||
JD Audit | Audit | 2001 – 2001 |
KM Management | Management | 2000 – 2001 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (13) | ||
| Board of Directors | 2005 – 2008 | |
| Board of Directors | 2015 – 2023 | |
| Chairman | 2001 – 2008 | |
| Board of Directors | 2003 – 2005 | |
| Chairman | 2023 – 2025 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2008 – 2015 | |
| Board of Directors | 2000 – 2001 | |
| Chairman | 2014 – 2015 | |
| Board of Directors | 2001 – 2008 | |
| Board of Directors | 2014 – 2020 | |
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2017 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tromp Medical ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjarne Alhøj | Management | 0 companies |
| Jens Danstrup Larsen | Audit | 0 companies |
| Kim Madsen | Management | 0 companies |
| Bjørn Leitås | Board of Directors | 0 companies |
| Boudewijn Antonius Johanne Maria Andreoli | Board of Directors | 0 companies |
| Øyvind Lars Solbakken | Chairman | 0 companies |
| Ronald Josephus Adrianus Maria Andreoli | Board of Directors | 0 companies |
| Torgny Bergerstam | Board of Directors | 0 companies |
| Konrad Cornelis Norbert Eichberger | Chairman | 0 companies |
| Cornelis Vlasblom | Board of Directors | 0 companies |
| Hans-Petter Prestby | Board of Directors | 0 companies |
| Peter Andreas Stakemann | Board of Directors | 0 companies |
| Henri van der Vegte | Board of Directors | 0 companies |
| Daan van Manen | Chairman | 0 companies |
| Bjørn Poetzsch | Chairman | 0 companies |
| Kjell Larsen | Board of Directors | 0 companies |
| Even Guttormsen | Board of Directors | 0 companies |
| Menno Wink | Board of Directors | 0 companies |
| Cato Wilberg Nilsen | Board of Directors | 0 companies |